This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Albumin iodinated I-125 serum is a radiopharmaceutical diagnostic agent indicated for use in the determination of total blood and plasma volume.
- Generic Name
- Albumin iodinated I-125 serum
- DrugBank Accession Number
- DB09429
- Background
I-125 iodinated albumin is a radiolabeled albumin-based diagnostic agent used in the determination of total blood and plasma volume.1
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Protein Based Therapies
Blood factors - Protein Chemical Formula
- Not Available
- Protein Average Weight
- Not Available
- Sequences
- Not Available
- Synonyms
- 125 I HSA
- 125 I-HSA
- 125-I-HSA
- Albumin, blood serum, labeled with iodine-125
- Albumin, iodinated I 125 serum
- Albumin,iodinated I-125 serum
- Albumin,iodinated serum,I-125
- Albumotope I-125
- HSA I-125
- Human albumin I-125
- Human serum albumin I-125
- Iodinated (125 I) human serum albumin
- Iodinated (125I) human serum albumin
- Iodinated I 125 serum albumin
- Iodinated I-125 serum albumin
Pharmacology
- Indication
I-125 iodinated albumin is used in the determination of total blood and plasma volume.1
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Jeanatope Injection, solution 1000 uCi/1mL Intravenous Iso-Tex Diagnostics, Inc. 2022-03-09 Not applicable US 
Jeanatope Injection, solution 0.01 mCi/1mL Intravenous Iso-Tex Diagnostics, Inc. 1990-06-01 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- Not Available
- Kingdom
- Organic Compounds
- Super Class
- Organic Acids
- Class
- Carboxylic Acids and Derivatives
- Sub Class
- Amino Acids, Peptides, and Analogues
- Direct Parent
- Peptides
- Alternative Parents
- Not Available
- Substituents
- Not Available
- Molecular Framework
- Not Available
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 68WQQ3N9TI
- CAS number
- Not Available
References
- General References
- DailyMed: Jeanatope (iodinated I-125 albumin) for injection [Link]
- External Links
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, solution Intravenous 0.01 mCi/1mL Injection, solution Intravenous 1000 uCi/1mL - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at November 30, 2015 19:10 / Updated at October 06, 2020 17:43